SBIR/STTR Research Award

Novel technologies for improved slide quality of pancreatic fine-needle aspirates

Award identifier 3ede655fcec676577f0b93b61745e5829c2697d433385ac05ccd79fda09749edAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$301,009

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
AFFINERGY, LLC
Proposal award date
2016-07-01
Contract end date
2018-06-30
UEI
YJQ6K1QMS488
Solicitation number
PA15-269
Topic code
300

Research abstract

DESCRIPTION provided by applicant Endoscopic ultrasound guided fine needle aspiration biopsy is the standard technique for diagnosis and staging of suspicious pancreatic lesions Unfortunately blood and other unwanted debris are frequently present in these fine needle aspirates thus diluting and obscuring cells of interest Subsequent slide preparations from such aspirates are suboptimal leading to non diagnostic outcomes that necessitate repeat FNA biopsies and or additional procedures adding to both time and cost If the repeat testing remains inconclusive then the patients are guided towards surgical biopsies for diagnostic confirmation However surgery is not only expensive and morbid but may be contraindicated in most patients with advanced disease In such inoperable patients non surgical FNA samples are often the only cytological specimens available to the clinicians for diagnosis Hence there is a considerable need to develop a product that can improve the consistency and quality of FNA slide preparations as well as facilitate ancillary molecular testing on the slides To this end Affinergy has identified multiple high affinity peptides that specifically bind to pancreatic cells but not to red and white blood cells In this application we propose to develop peptide coated glass slides which will provide a simple and rapid method for preparing optimal pancreatic FNA slides for improved diagnostic outcomes At the conclusion of Phase I we expect to have established the feasibility of using our peptide modified slides for cytological analysis of pancreatic FNA specimens which can then be validated during Phase II utilizing clinical samples PUBLIC HEALTH RELEVANCE Diagnostic confirmation of pancreatic carcinomas is often challenging in pancreatic fine needle aspirates contaminated with blood and other debris In this proposal we will develop a novel method of improving visualization of slide preparations by specifically capturing diagnostic cells while removing obscuring contaminants

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

75 SBIR/STTR records share this UEI (2005–2023). Reported award amounts total $59,804,968. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.